Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 077038

Expand all

CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)
EQ 10MG BASE
Marketing Status: Prescription

Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CITALOPRAM HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077038
Product Number: 001
Approval Date: Oct 28, 2004
Applicant Holder Full Name: DR REDDYS LABORATORIES LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)
EQ 20MG BASE
Marketing Status: Prescription

Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CITALOPRAM HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077038
Product Number: 002
Approval Date: Oct 28, 2004
Applicant Holder Full Name: DR REDDYS LABORATORIES LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)
EQ 40MG BASE
Marketing Status: Prescription

Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CITALOPRAM HYDROBROMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077038
Product Number: 003
Approval Date: Oct 28, 2004
Applicant Holder Full Name: DR REDDYS LABORATORIES LTD
Marketing Status:  Prescription
Patent and Exclusivity Information